Index. Infect Dis Clin N Am 20 (2006) Note: Page numbers of article titles are in boldface type.

Transcription

1 Infect Dis Clin N Am 20 (2006) Index Note: Page numbers of article titles are in boldface type. A Abortion storms, 363 Adult intestinal toxemia botulism, 317 Allergen Pharmaceuticals, 315 Alphaviruses agent, American Society for Microbiology, 195 Anthrax, clinical manifestations of, cutaneous, 237 gastrointestinal, genetics of, hemorrhagic meningoencephalitis, history of, inhalational victims of recognition of, microbiologic diagnosis of, microbiology of, pathogenesis of, prevention of postexposure, treatment of, current, decontamination in, emerging therapies in, 242 human vaccination in, infection control in, investigational therapies in, 242 vaccines in, virulence factors in, Antibiotic(s) in plague prevention, 284 Antonine plague, Galen s description of, historical background of, Arenaviridae of, Arenaviruses Argentine hemorrhagic fever of, Avian influenza agent, B Bacteria agent, Biologic agents deliberate release of recognition of, suddenness of, unusual clinical presentation of, 220 unusual geographic, temporal, or demographic clustering in, 220 Biologic weapons plaque as, Biological warfare plague-related historical aspects of, Biological weapons system components of, BioSense in syndromic surveillance of bioterrorism agents, 222 Bioterrorism, See also Bioterrorism preparedness. anthrax in, See also Anthrax. defined, 179 historical perspective of, postbacterial cultivation era, post World War I era, prebacterial cultivation era, /06/$ - see front matter Ó 2006 Elsevier Inc. All rights reserved. doi: /s (06)00050-x id.theclinics.com

2 476 INDEX Bioterrorism agents, , biologic agents deliberate release of recognition of, infectious diseases as surveillance of, potential category B, See also Category B potential bioterrorism agents. category C, See also Category C potential bioterrorism agents. emerging pathogens, Francisella tularensis as, surveillance for criteria for, syndromic, BioSense in, 222 ESSENCE in, 222 RODS in, types of, Bioterrorism preparedness, avenues of, biohazard containment in decontamination and infection control procedures, personal protective equipment, global avenues of, obstacles to, pharmaceutical readiness, public health laws in, public health system in, rationale for, 185 Bioterrorism preparedness and response microbial forensics in, See also Microbial forensics. Bioterrorism preparedness program backbone of elements of daily practice in, communication in ensurance of appropriate internal and external mechanisms of, community preparedness in emphasis on, 452 dissemination of, 447 ensurance of familiarity by all key stakeholders in, 447 feasibility and viability of assessment of, improving collaboration with community physicians, area hospitals, and local health departments in, in hospital setting implementation of practical aspects of, intensified surveillance of incorporation of internal mechanisms for, 448 key components of building redundancy for, 450 incorporation of flexibility in, 450 periodical testing of drills for, surge capacity in addressing logistics involving, written plan, Bioterrorism weapons smallpox as, See also Smallpox. Bolivian hemorrhagic fever, 374 Botulinum toxin as weapon, intentional aerosolized, intentional foodborne, intentional injected, intentional water contamination by, 321 many faces of, microbiology and, Botulism, adult intestinal toxemia, 317 causes of, clinical syndromes of, diagnosis of, epidemiology of, 315 foodborne, iatrogenic, 318 infant, 317 inhalational, suspected cases of protocol for, 324 treatment of, wound, 317 Brucella sp agents, Bubonic plague, 255 Bunyaviridae of, Bunyavirus genus, 362 Hantavirus genus, Nairovirus genus, Phlebovirus genus,

3 Bunyavirus(es) agent, 408 Bunyavirus genus of, Burkholderia sp agent, B mallei, B pseudomallei, C Campylobacter jejuni agent, 411 Category B potential bioterrorism agents, alphaviruses, Brucella sp, bunyaviruses, 408 Burkholderia sp B mallei, B pseudomallei, Chlamydia psittaci, Coxiella burnetti, described, 395 EEE, epsilon toxin of Clostridium perfringens, flaviviruses, foodborne and waterborne pathogens, bacteria, protozoa, viruses, ricin, Rickettsia prowazwkii, staphylococcal enterotoxin B, types of, 396 VEE, WEE, Category C potential bioterrorism agents, avian influenza, described, 423 emerging pathogens, genetically engineered biologic weapons, 436 hantaviruses, monkeypox virus, multidrug-resistant tuberculosis, 430 Nipah virus, pandemics of influenza, SARS, INDEX 477 tick-borne encephalitis complex, tick-borne hemorrhagic fever viruses, West Nile virus, yellow fever virus, Centers for Disease Control and Prevention (CDC), 179, 213, 395, 468 in smallpox diagnosis, 339 Chickenpox smallpox vs, Chlamydia psittaci agent, Chordopoxvirinae, Clostridium botulinum botulism due to, 315 Clostridium perfringens episilon toxin of as category B potential bioterrorism agent, Congo-Crimean hemorrhagic fever of, Coxiella burnetti agent, Cryptosporidium parvum Cutaneous anthrax, 237 Cyclospora cayetanensis D Decontamination in anthrax prevention, Dengue fever of, Dengue virus Department of Defense, 195, 347 Department of Health and Human Services, 347

4 478 INDEX E Eastern equine encephalitis (EEE) agent, Ebola virus of, EEE. See Eastern equine encephalitis (EEE). Electronic Surveillance System for the Early Notification of Community-based Epidemics (ESSENCE) in syndromic surveillance of bioterrorism agents, 222 Encephalitis smallpox vaccination and, Encephalopathy smallpox and, 339 Endemic disease. See also Viral hemorrhagic fevers. current status of, strategies for control of, Entamoeba histolytica Enterocytozoon bieneusi agent, 414 Entomopoxvirinae, 329 Epidemiology studies in microbial forensics, Epsilon toxin of Clostridium perfringens agent, Escherichia coli agent, 411 ESSENCE. See Electronic Surveillance System for the Early Notification of Community-based Epidemics (ESSENCE). Exzema vaccinatum smallpox vaccination and, F FBI, 468 Fever(s). See also specific types, eg, Lassa fever. hemorrhagic viral, See also Viral hemorrhagic fevers. Filoviridae of, Flaviviridae of, Flavivirus(es) agent, Florida Department of Health, 455 Fogarty International Center, 196 Foodborne botulism, Foodborne contamination intentional botulinum toxin and, 321 Forensics microbial, See also Microbial forensics. Francisella tularensis as potential bioterrorism agent, G Gastrointestinal anthrax, Genetic(s) of anthrax, Genetically engineered biologic weapons agent, 436 Giardia lamblia Glandular tularemia, Global Outbreak Alert and Response Network, Guanarito virus of, 373 H Hantavirus(es) agent,

5 Hantavirus genus of, Harvard Medical School, 333 Hemorrhagic fever(s) viral, See also Viral hemorrhagic fevers. Hemorrhagic fever viruses tick-borne as category C potential bioterrorism agent, Hemorrhagic meningoencephalitis, Hepatitis A virus agent, I Iatrogenic botulism, 318 Immunization for plague, Immunofluorescence in tularemia diagnosis, 302 Infant botulism, 317 Infection control in anthrax prevention, Infectious diseases bioterrorism agents causing surveillance of, Influenza(s) avian as category C potential bioterrorism agent, pandemics of as category C potential bioterrorism agent, Inhalational anthrax victims of recognition of, Inhalational botulism, J Junin virus of, Justinian plague, historical background of, 263 historical importance of, infectious disease aspects of, 266 ProcopiusÕ description of, INDEX 479 K Kyasanur Forest disease virus and hemorrhagic fever of, L Laboratory Response Network (LRN), 455, 468 Lassa fever of, Listeria moncytogenes agent, 412 LRN. See Laboratory Response Network (LRN). M Machupovirus of, 374 Marburg virus of, Meningoencephalitis hemorrhagic, Microbial forensics, described, epidemiology studies in, methods in, non-nucleic acid based methods, nucleic acid based methods, national system for, 468 scenarios, Microbiology of anthrax, Microsporidia Military Vaccination Program and Selective Civilian Vaccination Program for , 347 Model Act, Model State Emergency Health Powers Act,

6 480 INDEX Monkeypox virus agent, Mosquito-borne flavivirus hemorrhagic fevers 367 Multidrug-resistant tuberculosis agent, 430 Myopericarditis smallpox vaccination and, 346 N Nairovirus genus of, NASA Goddard Space Flight Center, 196 National Center for Environmental Prediction, 196 National Institute of Allergy and Infectious Diseases (NIAID) Biodefense Research, 395 National Institutes of Health, 196 Neonate(s) smallpox in, 340 New York City Board of Health, 347 Nipah virus agents, Non-nucleic acid based methods in medical forensics, Noroviruses agent, 412 Nucleic acid based methods in medical forensics O Ocular complications smallpox vaccination and, 345 smallpox-related, Oculoglandular tularemia, 299 Omsk hemorrhagic fever virus of, Oropharyngeal tularemia, 299 Osteomyelitis smallpox, 340 P Pharmaceutical readiness in bioterrorism preparedness, Phlebovirus genus of, Pirital virus 361 Plague(s), See also specific mtypes, eg, Justinian plague. ancient cause of, 256 antibiotic prophylaxis for, 284 Antonine, as biologic weapon, bacteriology of, biological warfare related to historical aspects of, bubonic, 255 causative agent of, 254 clinical manifestations of, 254 clinical presentations of, described, 273 evolutionary genomics of, global epidemiology of, immunization for, impact on human history, infection control in, Justinian, laboratory diagnosis of, management of, natural foci of, of antiquity, Antonine plague, Justinian plague, plague of Athens, pandemics of, pathogenesis of, pneumonic, 256 prevention of, septicemic, virulence factors for, Yersinia pestis and, 273 Plague bacillus, 254 Plague of Athens, historical background of, historical importance of, 260 infectious disease aspects of, Thucydides description of, Pneumonic plague, 256

7 Polymerase chain reaction (PCR) in tularemia diagnosis, 301 Poxviridae, 329 Pregnancy smallpox during, 340 vaccinia in smallpox vaccination and, Protein(s) SNARE, 314 Protozoa 414 Public health directors state and territorial, Public Health Laboratories, 468 Public health laws in bioterrorism preparedness, Public Health Security and Bioterrorism Preparedness and Response Act, 195 Public health system in bioterrorism preparedness, emergency response capability in, 190 laboratory preparedness in, 190 recognition in, training in, Punta toro virus infection 363 R Real-time Outbreak and Disease Surveillance (RODS) in syndromic surveillance of bioterrorism agents, Respiratory tularemia, 301 Ricin agent, Rickettsia prowazwkii agent, Rift Valley fever infection of, RODS. See Real-time Outbreak and Disease Surveillance (RODS). INDEX 481 S Sabia virus of, 373 Salmonella sp agent, SARS. See Severe acute respiratory syndrome (SARS). Select Agent Program, 195 Septicemic plague, Severe acute respiratory syndrome (SARS) agent, Shigella sp agent, 411 Smallpox as bioterrorism weapon, chickenpox vs, clinical presentation of, complications of, contagious period for, 336 diagnosis of, CDC assistance in, 339 differential diagnosis of, 341 during pregnancy, 340 encephalopathy with, 339 epidemiology of, flat malignant, 337 hemorrhagic fulminate, 337 history of, in neonates, 340 incubation period for, medical conquest of, modified, 337 ocular complications of, osteomyelitis due to, 340 pathophysiology of, 335 physical properties of, prodrome for, 336 suspected cases of procedures for, treatment of, typical, 336 vaccinations for complications of, Military Vaccination Program and Selective Civilian Vaccination Program for , 347 variola sine eruptione variola sine exanthemata, SNARE proteins, 314

8 482 INDEX Standardized Emergency Management System, Staphylococcal enterotoxin B agent, State Departments Bureau of Population, Refugees and Migration, 196 T Tick-borne encephalitis complex agent, Tick-borne flavivirus hemorrhagic fevers Tick-borne hemorrhagic fever viruses agent, Tuberculosis multidrug-resistant as category C potential bioterrorism agent, 430 Tularemia, as emerging disease, 294 clinical manifestations of, diagnosis of, culture in, 301 immunofluorescence in, 302 lymphocyte stimulation in, PCR in, 301 serology in, skin test in, 301 ecology of, epidemiology of, geographic distribution of, glandular, historical background of, oculoglandular, 299 oropharyngeal, 299 pathogenesis of, prevention of, 304 respiratory, 301 routes of, treatment of, typhoidal, 299 ulceroglandular, Typhoidal tularemia, U Ulceroglandular tularemia, United States Army Medical Research Institute of Infectious Diseases, 359 US Defense Against Weapons of Mass Destruction Act, 195 US Department of Defense Global Emerging Infections Surveillance and Response System, 196 USAID, 196 V Vaccination(s) for smallpox complications of, in anthrax prevention, Vaccine(s) for anthrax vaccines in development, for smallpox, Vaccine Adverse Event Reporting System, 347 Vaccinia in pregnancy smallpox vaccination and, Vaccinia necrosum progressive vaccinia smallpox vaccination and, 344 Variola residua smallpox and, Variola sine eruptione variola sine exanthemata, Variolae vaccinae, 332 Variolation, 332 VEE. See Venezuelan equine encephalitis (VEE). Venezuelan equine encephalitis (VEE) agent, Venezuelan hemorrhagic fever of, 373 Vibrios chloerae agent, Viral hemorrhagic fevers, Arenaviridae and clinical presentation and management of, Arenaviruses and

9 Bunyaviridae and clinical presentation and management of, causes of RNA viral families, 359 of, Filoviridae and clinical presentation and management of, Flaviviridae and clinical presentation and management of, viruses due to threat posed by, Virus(es). See specific types, eg, Nipah virus. agent, W Washington Post, 349 Water contamination intentional botulinum toxin and, 321 INDEX 483 Weapon botulinum toxin as, WEE. See Western equine encephalitis (WEE). West Nile virus agent, Western equine encephalitis (WEE) agent, Whitewater Arroyo virus of, 374 World Health Organization (WHO), 334 Wound botulism, 317 Y Yellow fever virus agent, of, Yersinia sp Y enterocolitica as category B potential bioterrorism agent, 412 Y pestis plague due to, 273